emeraldcloudlab.comHealthcare / BioTech & PharmaFounded: 2009Funding to Date: $459.52MM
Emerald Cloud Lab (ECL) is a unique, remotely operated research facility handling all lab aspects, from method design to waste disposal. It features the ECL Command Center, allowing users to control over 200 instrument models for in vitro biology and chemistry experiments. ECL operates 24/7 and caters to various research areas, particularly biotechnology and pharmaceuticals. Its advanced equipment includes HPLC, GC, Mass Spectrometers, NMR, PCR, and more, enabling comprehensive and remote research capabilities.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
03/06/2024 | New Series A | $135.64MM | $xx.xx | $96.18MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
135,642,299
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/06/2024 | New Series B-2 | $6.66MM | $xx.xx | $96.18MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
39,881,617
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/06/2024 | New Series B-1 | $37.44MM | $xx.xx | $96.18MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
179,320,708
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|